Actively Recruiting
Sarcopenia in Colorectal Cancer Patients, Intervention Study
Led by Hospital Universitari de Bellvitge · Updated on 2025-05-20
370
Participants Needed
1
Research Sites
269 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The sarcopenia is a new concept for evaluating the functional status of patients, introduced during the last 20 years. This is defined as the relationship between the deterioration of muscle mass and the decrease in strength, the metabolic rate, the aerobic capacity and subsequently the evaluation of the functional status. The sarcopenia has been estimated to affect 5% to 13% of people aged between 60 and 70 years, increasing from 11% to 50% in those aged 80 years and older. In a study by Lieffers et al. of a total of 234 patients with colorectal cancer, with a mean age of 63 years according to the values observed by Prado et al., the prevalence of sarcopenia would be around 39%, being able to reach up to 60% in patients with chronic diseases. The goal of this study is to compare the cumulative incidence of post-surgical complications due to infection at 30 days between the group of patients without sarcopenia and the group of patients with sarcopenia with an intervention based on a nutritional supplement + physical exercise.
CONDITIONS
Official Title
Sarcopenia in Colorectal Cancer Patients, Intervention Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 70 years or older
- Diagnosed with colon adenocarcinoma without synchronous metastases
- No urgent surgery needed
- ECOG performance status of 2 or less
- Not pregnant or lactating
- Signed informed consent form
- Able to follow study instructions
You will not qualify if you...
- Diagnosis of rectal cancer
- Any other cancer in the last 5 years
- Medical or mental condition preventing informed consent
- Uncontrolled or stable medical conditions
- Clinically significant heart disease such as congestive heart failure or symptomatic coronary disease
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08709
Actively Recruiting
Research Team
R
Ricardo Frago, Ph D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here